Book a Demo
Hannah Kuchler
Gray shield icon
Is this you?
Claim your profile.

Hannah Kuchler

Global Pharmaceutical Editor

AS SEEN ON
Financial Times

Preston's Summary

Hannah Kuchler is a Global Pharmaceutical Editor at the Financial Times. She leads the science and pharma team, focusing on topics such as pharmaceutical manufacturing, drugs and medication, consumer health, and wellness programs. Hannah's work has been featured in The Irish Times, Yahoo Finance, and Ars Technica, among others.

Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston

Geo Focus

Coverage Attributes:

Beta
Informative: 34 %
Promotional: 15 %
Opinion: 15 %
Data Driven: 13 %
Reviews: 13 %

Themes Covered:

Not enough data icon

Not enough data

Most Recent Topics:

  • Aging & Longevity
  • Pharmaceutical Manufacturing
  • Drugs & Medication
  • Consumer Health
  • Diet & Nutrition
  • Wellness Programs
  • Health News
  • Pharmaceutical Regulation

Pitching Insights

Hannah Kuchler's articles primarily focus on the healthcare and pharmaceutical industry, with an emphasis on vaccines, clinical trials, and pharmaceutical companies. She often cites data and government announcements in her coverage.

Given her extensive coverage of healthcare topics, she may be open to pitches from experts in the field who can provide insights into clinical trials, pharmaceutical regulations, or other relevant health-related developments. Pitches related to vaccine distribution strategies or advancements in gene-editing therapy could also resonate well with Hannah.

As Hannah covers a broad spectrum of topics within the healthcare industry and frequently references government announcements and data sources, professionals with expertise in public health policies or regulatory affairs might find success when reaching out to her.

This information evolves through artificial intelligence and human feedback. Improve this profile .

Articles

© 2026 Intelligent Relations